No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
REXR240719P50000
- 0.75
- -0.45-37.50%
15min DelayClose Jul 19 15:59 ET
1.10High0.65Low
1.10Open1.20Pre Close51 Volume175 Open Interest50.00Strike Price4.29KTurnover508.71%IV-0.29%PremiumJul 19, 2024Expiry Date0.89Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6265Delta0.1496Gamma32.20Leverage Ratio-13.0804Theta0.0000Rho-20.17Eff Leverage0.0019Vega
Intraday
- 5D
- Daily
News
Real Estate Stocks Gain as Traders Look for Alternatives to Tech Stocks
A Quick Look at Today's Ratings for Rexford Industrial Realty Inc(REXR.US), With a Forecast Between $46 to $55
On Jul 19, major Wall Street analysts update their ratings for $Rexford Industrial Realty Inc(REXR.US)$, with price targets ranging from $46 to $55.Barclays analyst Brendan Lynch maintains with a
Express News | Rexford Industrial Realty Inc : Evercore ISI Raises Target Price to $55 From $54
A Quick Look at Today's Ratings for Rexford Industrial Realty Inc(REXR.US), With a Forecast Between $46 to $66
On Jul 18, major Wall Street analysts update their ratings for $Rexford Industrial Realty Inc(REXR.US)$, with price targets ranging from $46 to $66.BofA Securities analyst Camille Bonnel maintains
Buy Rating Justified by Strategic Acquisitions and Strong Financials for Rexford Industrial Realty
Analysts' Opinions Are Mixed on These Real Estate Stocks: Rexford Industrial Realty (REXR), Crown Castle (CCI) and First Industrial Realty (FR)
Comments
The Co-CEOs of the company, Michael Frankel and Howard Schwimmer, expressed their commitment to driving long-term shareholder value and stated their focus on executing value creation strategies for the benefit of their shareholders.
Press Release: Rexford Industrial Announces 10 Percent Increase in Quarterly Common Stock Dividend
$ArcBest(ARCB.US$ initiated at buy by Jefferies, announced target price at $110.00.
$Saia(SAIA.US$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone(AZO.US$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle(ORCL.US$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings(BILL.US$ was downg...
$Saia(SAIA.US$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone(AZO.US$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle(ORCL.US$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings(BILL.US$ was downg...
16
Upgrades
• $ABM Industries(ABM.US$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp(AMT.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight(CHD.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene(CNC.US$ : Credit Suisse Upgrades to Outperform from...
• $ABM Industries(ABM.US$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp(AMT.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight(CHD.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene(CNC.US$ : Credit Suisse Upgrades to Outperform from...
16
Gainers:
• $Array Technologies(ARRY.US$ +12.87% (also names new CEO)
• $Tufin Software Technologies(TUFN.US$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals(CTXR.US$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics(BTAI.US$ +19.22% (FDA ha...
• $Array Technologies(ARRY.US$ +12.87% (also names new CEO)
• $Tufin Software Technologies(TUFN.US$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals(CTXR.US$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics(BTAI.US$ +19.22% (FDA ha...
20
Read more